Target intelligence / Profile preview

CMC2 pseudogene 1 (CMC2P1)

Target
CMC2P1
Molecular classification
Other (Pseudogene)
01

Overview

CMC2 pseudogene 1 (CMC2P1) is a processed pseudogene derived from the ancestral CMC2 gene. Pseudogenes such as CMC2P1 typically arise from gene duplication or retrotransposition events and lack protein-coding capability due to mutations or loss of regulatory elements[2]. These genes do not encode functional proteins and are not considered classic molecular targets for drug development or therapy. While certain pseudogenes sometimes function as regulatory RNAs, sequestering microRNAs or modulating gene expression, there is no evidence in the literature indicating CMC2P1 has a specific functional or disease-related role[2]. In summary, CMC2P1 is not a protein-coding gene, receptor, enzyme, or therapeutic target. The entry “CMC2P1” is likely included in certain gene lists for completeness but should not be considered an actionable molecular target.

Other names
CMC2P1CMC2PCMC2P1 gene
02

Biological functions

Other (Pseudogenes can sometimes regulate gene expression via competing endogenous RNA mechanisms, but no known biological function is documented for CMC2P1 specifically[2])
03

Disease associations

Other (There is no documented evidence that CMC2P1 has a direct disease role; some pseudogenes can play regulatory roles, but CMC2P1 is not specifically implicated[2])

Beyond the preview

Go deeper on CMC2 pseudogene 1 (CMC2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CMC2 pseudogene 1 (CMC2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call